A Randomized Trial of Edivoxetine in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

• Published in: Journal of child and adolescent psychopharmacology Vol. 24; no. 4; pp. 190 - 200
• Main Authors: Lin, Daniel Y., Kratochvil, Christopher J., Xu, Wen, Jin, Ling, D'Souza, Deborah N., Kielbasa, William, Allen, Albert J.
• Format: Journal Article
• Language: English
• Published: United States Mary Ann Liebert, Inc 01.05.2014
• Subjects: Adolescent; Adrenergic Uptake Inhibitors - administration & dosage; Adrenergic Uptake Inhibitors - adverse effects; Adrenergic Uptake Inhibitors - therapeutic use; Attention Deficit Disorder with Hyperactivity - drug therapy; Attention deficit hyperactivity disorder; Central Nervous System Stimulants - therapeutic use; Child; Children & youth; Clinical trials; Dose-Response Relationship, Drug; Double-Blind Method; Drug therapy; Female; Humans; Male; Methylphenidate - therapeutic use; Morpholines - administration & dosage; Morpholines - adverse effects; Morpholines - therapeutic use; Original; Phenylethyl Alcohol - administration & dosage; Phenylethyl Alcohol - adverse effects; Phenylethyl Alcohol - analogs & derivatives; Phenylethyl Alcohol - therapeutic use; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome

The purpose of this study was to assess the efficacy and safety of edivoxetine (LY2216684), a selective norepinephrine reuptake inhibitor, in pediatric patients with attention-deficit/hyperactivity disorder (ADHD). A fixed-dose, randomized, double-blind, 8 week study was conducted in patients 6-17 y...